Stock·NASDAQ·Technology
Everspin Technologies, Inc. (MRAM)
- Market cap
- $342.60M
- Dividend yield
- 0.00%
- Street target
- $20.00median of 3 analysts
- 52-week range
- $7.35 $51.50
The short version
Where MRAM stands today, in four lines, and what CleaRank Financial AI makes of it.
MRAM at a glance
Everspin Technologies, Inc. (MRAM): Buy, 75/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($16.75 and $16.64).
- Earnings MRAM beat estimates in 4 of its last 7 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $20.3M and made no open-market purchases over the last 18 months.
Figures as of October 16, 2026.
CleaRank Financial AI
Everspin Technologies (MRAM) is currently trading at $14.07, below its 50-day and 200-day moving averages ($16.75 and $16.64), indicating a bearish technical trend.
The company has demonstrated impressive revenue growth of 41.9%, significantly outpacing the sector median of 24.2%. Recent earnings reports have also shown positive surprises, with the latest quarter beating estimates by 22.22%. Analysts maintain a strong buy consensus with a median price target of $20.00, suggesting a 42.1% upside potential. Despite these positive fundamental indicators, significant insider selling totaling $20.3 million across recent filings, with no insider purchases, presents a notable risk. The company's profit margin remains negative at -4.22%, and its EPS is also negative at -0.12. While revenue growth is strong, profitability remains a key challenge that investors are closely monitoring.
Only on CleaRank
Figures we compute ourselves from MRAM's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $14.07 is 16.0% below the 50-day simple moving average of $16.75.Price above its 200-day average ›
The price is 15.4% below the 200-day simple moving average of $16.64.50-day average above the 200-day ›
The 50-day average ($16.75) is 0.7% above the 200-day average ($16.64), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 15% of its 52-week range, between $7.35 and $51.50.
MRAM share price
Pick a period: each tab shows how far MRAM has moved over it, to the last close.
Today's trading
Where MRAM sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/3P/S below the sector median ›
The price-to-sales ratio of 5.32 is 29.9% below the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $-2.6M on revenue of $62.5M, a net margin of -4.2%.Beat estimates in most recent reports ›
MRAM beat the EPS estimate in 4 of its last 7 reports.
Key statistics
The headline figures for MRAM.
As of October 16, 2026, MRAM trades at $14.07, with a market value of $342.60M and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of MRAM's valuation, growth and risks.
Everspin Technologies exhibits strong revenue growth of 41.9%, significantly exceeding the sector median of 24.2%.
However, its valuation metrics are mixed, with a price-to-sales ratio of 5.32 compared to the sector median of 7.6. The company's profitability remains a concern, with a negative net profit margin of -4.22% and a negative EPS of -0.12. Its return on equity is also negative at -3.84%. The company's debt-to-equity ratio is a healthy 0.04, well below the sector average, indicating a strong balance sheet in terms of leverage. Despite the lack of current profitability, the strong revenue growth and positive analyst estimates for future earnings and revenue suggest potential for a turnaround. The current price of $14.07 is below the sector's median P/E ratio, but this is largely due to its negative EPS.
MRAM against the Technology sector
How MRAM compares with the median Technology stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, MRAM trades at 5.32x, -30% versus the sector average of 7.60x.
Return vs XLK: Since May 5, 2025, MRAM has gained 145.6% against a gain of 75.6% for XLK.
Performance against XLK
MRAM and the Technology sector fund over the same days.
Revenue and earnings
How much MRAM sells, and how much of it becomes profit.
Revenue growth: Revenue grew 9.5% in FY2025 to $55.2M, from $50.4M a year earlier.
Profit margin: The net margin was -1.1% in FY2025, down from 1.5% the year before.
Profitable: MRAM lost $586K in FY2025.
Earnings reality check
Did MRAM beat what analysts expected, and how did the stock react?
Earnings record: MRAM beat the analyst estimate in 4 of the last 7 quarters.
Market reaction: The stock fell in the first session after 3 of those 4 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 5, 2026after close | $0.09 | $0.11 | +22.22% | -3.04% | +5.70% |
| Mar 4, 2026after close | $0.12 | $0.11 | -8.33% | -15.52% | -15.20% |
| Nov 5, 2025after close | $0.04 | $0.06 | +50.00% | -17.19% | -14.62% |
| Aug 6, 2025after close | $0.03 | $0.03 | +0.00% | +1.52% | +6.90% |
| Apr 30, 2025after close | $0.03 | $0.02 | -33.33% | +11.70% | +10.75% |
| Feb 26, 2025after close | $0.06 | $0.13 | +116.67% | -1.41% | -4.04% |
| Jul 31, 2024after close | -$0.06 | -$0.03 | +50.00% | +2.30% | +0.00% |
As of October 16, 2026, MRAM has beaten the analyst EPS estimate in 4 of its last 7 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on August 5, 2026, came in 22.22% above the estimate and the stock moved -3.04% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 34.0, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 34.0 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of MRAM
The score, the reasoning behind it, and what could move the price next.
Everspin Technologies' stock is currently trading below its 50-day SMA of $16.75 and its 200-day SMA of $16.64, signaling a bearish trend.
The 14-day RSI is at 33.97, indicating bearish momentum and suggesting further downside potential. The MACD is also negative at -0.54, reinforcing the bearish sentiment. Volume on the latest trading day was 943,900, which is 23.6% above the average volume, suggesting increased selling pressure. The stock's position below key moving averages and its bearish RSI status point to potential further declines. The current price action suggests a lack of immediate bullish catalysts from a technical perspective. Investors should monitor the 50-day and 200-day SMAs as potential resistance levels on any upward price movement.
Strong Revenue Growth Exceeding Sector Averages ›
Everspin Technologies is demonstrating revenue growth of 41.9%, significantly outpacing the sector median of 24.2%, indicating strong market demand for its products.
Source: Company DataPositive Earnings Surprises ›
The company has delivered positive EPS surprises in its most recent earnings reports, suggesting improving operational efficiency and better-than-expected performance.
Source: Company DataPositive Analyst Ratings and Price Targets ›
Wall Street analysts maintain a 'Strong Buy' consensus with a median price target of $20.00, implying a substantial upside potential of 42.1% from the current stock price.
Source: Wall Street Summary
Significant Insider Selling ›
Over $20.3 million in insider sales have been recorded with no corresponding insider purchases.
Source: Insider SummaryBearish Technical Indicators ›
The stock is trading below its 50-day and 200-day moving averages ($16.75 and $16.64), and the 14-day RSI is in bearish territory, suggesting a negative short-to-medium term price trend.
Source: Technical Analysis
- A sustained break above the 50-day SMA at $16.75 and the 200-day SMA at $16.64 would be a key technical signal for a potential trend reversal.
Technical indicators
Momentum and trend for MRAM, from its daily closes.
As of October 16, 2026, with MRAM at $14.07, its 14-day RSI is 34.0 (showing bearish momentum without being oversold), its 50-day simple moving average is $16.75 and its 200-day is $16.64.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What MRAM moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, MRAM's 1-year correlation of daily returns is +0.41 with S&P 500 (SPY), +0.49 with Nasdaq 100 (QQQ), +0.28 with Bitcoin (BTC) and +0.19 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/2Most analysts rate it a buy ›
3 of 3 analysts rate it a buy or strong buy, 0 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $20.00 is 42.1% above the price.
MRAM Wall Street View
12-month price targets
The price, $14.07, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 12, 2026 | Maxim Group | Initiates | Buy |
| Aug 6, 2026 | Needham | Maintains | Buy |
| Apr 30, 2026 | Needham | Maintains | Buy |
As of October 16, 2026, 3 Wall Street analysts cover MRAM: 3 rate it a buy or strong buy, 0 a hold and 0 a sell or strong sell. Their 12-month price targets range from $19.00 to $38.00, with a median of $20.00, 42.1% above the price of $14.07.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
MRAM trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
MRAM moves about 4.4% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much MRAM tends to move, against the market and on its own.
The long record
MRAM's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 4.37% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 90.0%, from July 2017 to March 2020, regained by May 2026.Most 1-year holds ended higher ›
48% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $21,031, against $42,525 in the S&P 500 (SPY).
MRAM Drawdowns & Recovery
As of October 16, 2026, MRAM's worst peak-to-trough fall over the last 10 years with dividends reinvested was -90.0% (July 2017 to March 2020); it regained that peak by May 2026, 74 months after the low, and 48% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into MRAM in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: MRAM trailed the S&P 500 over this period: $21,031 against $42,525.
A $10,000 investment in MRAM in October 2016 would be worth about $21,031 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to MRAM, and which have not.
Strongest month, May: an average of +37.93%, up in 7 of 10 years.
Weakest month, March: an average of -10.40%, up in 1 of 10 years.
This month, October: has averaged -1.58%, up in 3 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, MRAM's strongest calendar month has been May (average +37.93%, up in 7 of 10 years) and its weakest March (average -10.40%, up in 1 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in MRAM, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in MRAM today could grow to about $19,469 by 2036 in the base case, with a 90th-percentile outcome near $147,707 and a 10th-percentile outcome around $2,566. Projections are statistical simulations, not guarantees.
MRAM Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $18.37 for MRAM by 2030 in the base case, from $14.07 today (1.3x over 4 years). The 10th-percentile path ends near $5.10. These are outcomes of a Monte Carlo simulation run on MRAM's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $7.92 | $15.04 | $28.54 | |
| 2028 | $6.50 | $16.08 | $39.79 | |
| 2029 | $5.66 | $17.18 | $52.13 | |
| 2030 | $5.10 | $18.37 | $66.16 | |
| 2031 | $4.68 | $19.63 | $82.27 |
Method: a lognormal simulation of MRAM's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
MRAM insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought MRAM shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 16, 2026, MRAM insiders reported 29 open-market sales worth $20.3M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Sanjeev Aggarwal
Chief Executive Officer
|
Sell | 19.6K | $373.4K |
| Oct 2, 2026 | Sean Michael Dougherty
Officer
|
Sell | 7.7K | $146.7K |
| Oct 2, 2026 | William Earl Cooper
Chief Financial Officer
|
Sell | 3.1K | $59.4K |
| Aug 10, 2026 | Vikas Choudhary
Director
|
Grant | 15.7K | - |
| Aug 4, 2026 | William Earl Cooper
Chief Financial Officer
|
Grant | 8.6K | - |
| Aug 4, 2026 | Sean Michael Dougherty
Officer
|
Grant | 8.6K | - |
| Aug 4, 2026 | Lawrence G Finch
Director
|
Grant | 1.1K | - |
| Jul 6, 2026 | Sanjeev Aggarwal
Chief Executive Officer
|
Sell | 36.3K | $713.1K |
| Jul 6, 2026 | William Earl Cooper
Chief Financial Officer
|
Sell | 1.8K | $35.8K |
| Jul 6, 2026 | Sean Michael Dougherty
Officer
|
Sell | 422 | $8.3K |
| Jul 1, 2026 | Sanjeev Aggarwal
Chief Executive Officer
|
Sell | 30.9K | $690.0K |
| Jul 1, 2026 | William Earl Cooper
Chief Financial Officer
|
Sell | 1.5K | $34.6K |
| Jul 1, 2026 | Sean Michael Dougherty
Officer
|
Sell | 358 | $8.0K |
| May 29, 2026 | Lawrence G Finch
Director
|
Sell | 310.1K | $8.5M |
| May 21, 2026 | Darin G Billerbeck
Director
|
Grant | 3.9K | - |
| May 21, 2026 | Lawrence G Finch
Director
|
Grant | 3.9K | - |
| May 21, 2026 | Glen W. Hawk
Director
|
Grant | 3.9K | - |
| May 21, 2026 | Tara Long
Director
|
Grant | 3.9K | - |
| May 21, 2026 | Douglas M Mitchell
Director
|
Grant | 3.9K | - |
| May 21, 2026 | Geoffrey George Ribar
Director
|
Grant | 3.9K | - |
| May 20, 2026 | Geoffrey George Ribar
Director
|
Sell | 27.5K | $793.6K |
| May 20, 2026 | William Earl Cooper
Chief Financial Officer
|
Sell | 10.0K | $291.3K |
| May 20, 2026 | Sanjeev Aggarwal
Chief Executive Officer
|
Option | 51.0K | $316.3K |
| May 18, 2026 | Sanjeev Aggarwal
Chief Executive Officer
|
Sell | 111.0K | $3.7M |
| May 18, 2026 | Sanjeev Aggarwal
Chief Executive Officer
|
Option | 111.0K | $879.8K |
| May 15, 2026 | Glen W. Hawk
Director
|
Sell | 48.6K | $1.8M |
| May 11, 2026 | Darin G Billerbeck
Director
|
Sell | 30.0K | $1.1M |
| May 11, 2026 | Darin G Billerbeck
Director
|
Option | 30.0K | $255.6K |
| May 6, 2026 | William Earl Cooper
Chief Financial Officer
|
Sell | 11.0K | $239.3K |
| May 6, 2026 | Lawrence G Finch
Director
|
Grant | 637 | - |
| May 4, 2026 | Sanjeev Aggarwal
Chief Executive Officer
|
Sell | 28.5K | $557.2K |
| Apr 1, 2026 | Sanjeev Aggarwal
Chief Executive Officer
|
Sell | 19.4K | $178.8K |
| Apr 1, 2026 | William Earl Cooper
Chief Financial Officer
|
Sell | 1.5K | $14.3K |
| Mar 31, 2026 | Sanjeev Aggarwal
Chief Executive Officer
|
Grant | 310.8K | - |
| Mar 31, 2026 | William Earl Cooper
Chief Financial Officer
|
Grant | 80.4K | - |
| Mar 31, 2026 | Sean Michael Dougherty
Officer
|
Grant | 18.0K | - |
| Mar 11, 2026 | Lawrence G Finch
Director
|
Grant | 1.5K | - |
| Feb 4, 2026 | Sanjeev Aggarwal
Chief Executive Officer
|
Option | 7.1K | $47.3K |
| Jan 7, 2026 | William Earl Cooper
Chief Financial Officer
|
Sell | 6.8K | $82.1K |
| Jan 5, 2026 | Sanjeev Aggarwal
Chief Executive Officer
|
Sell | 25.3K | $259.0K |
| Nov 25, 2025 | Tara Long
Director
|
Sell | 7.5K | $57.8K |
| Nov 12, 2025 | Lawrence G Finch
Director
|
Grant | 1.5K | - |
| Nov 10, 2025 | Darin G Billerbeck
Director
|
Sell | 12.0K | $113.0K |
| Nov 10, 2025 | Darin G Billerbeck
Director
|
Option | 12.0K | $86.4K |
| Oct 2, 2025 | Sanjeev Aggarwal
Chief Executive Officer
|
Sell | 17.1K | $174.0K |
| Aug 13, 2025 | Lawrence G Finch
Director
|
Grant | 2.2K | - |
| Aug 8, 2025 | Sanjeev Aggarwal
Chief Executive Officer
|
Sell | 1.8K | $10.6K |
| Aug 7, 2025 | Sanjeev Aggarwal
Chief Executive Officer
|
Sell | 1.4K | $8.3K |
| Aug 5, 2025 | Sean Michael Dougherty
Officer
|
Grant | 80.0K | - |
| Jul 3, 2025 | Sanjeev Aggarwal
Chief Executive Officer
|
Sell | 30.0K | $198.6K |
| May 28, 2025 | David Schrenk
Officer
|
Sell | 3.8K | $21.9K |
| May 22, 2025 | Darin G Billerbeck
Director
|
Grant | 20.3K | - |
| May 22, 2025 | Lawrence G Finch
Director
|
Grant | 20.3K | - |
| May 22, 2025 | Glen W. Hawk
Director
|
Grant | 20.3K | - |
| May 22, 2025 | Tara Long
Director
|
Grant | 20.3K | - |
| May 22, 2025 | Geoffrey George Ribar
Director
|
Grant | 20.3K | - |
| May 7, 2025 | Lawrence G Finch
Director
|
Grant | 2.3K | - |
| May 5, 2025 | David Schrenk
Officer
|
Sell | 20.0K | $114.0K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.